Institution
American Cancer Society
Nonprofit•Atlanta, Georgia, United States•
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.
Papers published on a yearly basis
Papers
More filters
TL;DR: Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of post-treatment care by primary care clinicians as discussed by the authors.
Abstract: Prostate cancer survivors approach 2.8 million in number and represent 1 in 5 of all cancer survivors in the United States. While guidelines exist for timely treatment and surveillance for recurrent disease, there is limited availability of guidelines that facilitate the provision of posttreatment clinical follow-up care to address the myriad of long-term and late effects that survivors may face. Based on recommendations set forth by a National Cancer Survivorship Resource Center expert panel, the American Cancer Society developed clinical follow-up care guidelines to facilitate the provision of posttreatment care by primary care clinicians. These guidelines were developed using a combined approach of evidence synthesis and expert consensus. Existing guidelines for health promotion, surveillance, and screening for second primary cancers were referenced when available. To promote comprehensive follow-up care and optimal health and quality of life for the posttreatment survivor, the guidelines address health promotion, surveillance for prostate cancer recurrence, screening for second primary cancers, long-term and late effects assessment and management, psychosocial issues, and care coordination among the oncology team, primary care clinicians, and nononcology specialists. A key challenge to the development of these guidelines was the limited availability of published evidence for management of prostate cancer survivors after treatment. Much of the evidence relies on studies with small sample sizes and retrospective analyses of facility-specific and population databases.
316 citations
University of Washington1, Fred Hutchinson Cancer Research Center2, University of Southern California3, University of North Carolina at Chapel Hill4, National Institutes of Health5, University of Nantes6, German Cancer Research Center7, Kaiser Permanente8, American Cancer Society9, Harvard University10, University of Chicago11, Translational Genomics Research Institute12, Vanderbilt University13, University of Toronto14, New York University15, University of Melbourne16, Ontario Institute for Cancer Research17, Ohio State University18, Yonsei University19, Sun Yat-sen University20, University of Hawaii at Manoa21, Mayo Clinic22, Massey University23, Yeshiva University24, University of Pittsburgh25, University of Utah26, Fudan University27, University of Ottawa28
TL;DR: In a large genome-wide association study, polymorphisms close to nucleic acid binding protein 1 (which encodes a DNA-binding protein involved in DNA repair) with colorectal tumor risk and polymorphisms in laminin gamma 1, cyclin D2, and T-box 3 are associated.
314 citations
International Agency for Research on Cancer1, deCODE genetics2, National Institutes of Health3, University of Toronto4, German Cancer Research Center5, Harvard University6, Dartmouth College7, University Health Network8, American Cancer Society9, University of Texas MD Anderson Cancer Center10, Russian Academy11, Nofer Institute of Occupational Medicine12, Curie Institute13, Charles University in Prague14, Norwegian University of Science and Technology15, Fred Hutchinson Cancer Research Center16, French Institute of Health and Medical Research17, University of Tartu18, University of Bergen19, University of Geneva20, Pomeranian Medical University21, Imperial College London22, Institut Gustave Roussy23, Utrecht University24, Academy of Athens25, University of Cambridge26, Umeå University27, University of Tromsø28, Council on Education for Public Health29, Baylor College of Medicine30, Heidelberg University31, University of Göttingen32, Cambridge University Hospitals NHS Foundation Trust33
TL;DR: The analysis demonstrates that imputation can identify rare disease-causing variants with substantive effects on cancer risk from preexisting genome-wide association study data and provides further evidence for inherited genetic susceptibility to lung cancer and its biological basis.
Abstract: We conducted imputation to the 1000 Genomes Project of four genome-wide association studies of lung cancer in populations of European ancestry (11,348 cases and 15,861 controls) and genotyped an additional 10,246 cases and 38,295 controls for follow-up. We identified large-effect genome-wide associations for squamous lung cancer with the rare variants BRCA2 p.Lys3326X (rs11571833, odds ratio (OR) = 2.47, P = 4.74 x 10(-20)) and CHEK2 p.Ile157Thr (rs17879961, OR = 0.38, P = 1.27 x 10(-13)). We also showed an association between common variation at 3q28 (TP63, rs13314271, OR = 1.13, P = 7.22 x 10(-10)) and lung adenocarcinoma that had been previously reported only in Asians. These findings provide further evidence for inherited genetic susceptibility to lung cancer and its biological basis. Additionally, our analysis demonstrates that imputation can identify rare disease-causing variants with substantive effects on cancer risk from preexisting genome-wide association study data.
314 citations
TL;DR: An update to the American Cancer Society guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented.
Abstract: An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid-based cytology and HPV DNA testing.
314 citations
TL;DR: Cigarette smoking prevalence reaches a peak between ages 20 and 40 among both males and females and then decreases and smoking prevalence is higher among males than among females and higher among blacks than among whites.
314 citations
Authors
Showing all 1345 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Walter C. Willett | 334 | 2399 | 413322 |
| Meir J. Stampfer | 277 | 1414 | 283776 |
| Frank B. Hu | 250 | 1675 | 253464 |
| David J. Hunter | 213 | 1836 | 207050 |
| Edward Giovannucci | 206 | 1671 | 179875 |
| Irving L. Weissman | 201 | 1141 | 172504 |
| Bernard Rosner | 190 | 1162 | 147661 |
| Susan E. Hankinson | 151 | 789 | 88297 |
| Paolo Boffetta | 148 | 1455 | 93876 |
| Jeffrey A. Bluestone | 143 | 515 | 77080 |
| Richard D. Smith | 140 | 1180 | 79758 |
| Garth D. Illingworth | 137 | 505 | 61793 |
| Brian E. Henderson | 137 | 712 | 69921 |
| Ahmedin Jemal | 132 | 500 | 380474 |
| Michael J. Thun | 129 | 392 | 79051 |